The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines

By Baudner B.C.   Giuliani M.M.   Verhoef J.C.   Rappuoli R.   Junginger H.E.   Giudice G.D.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3837-3844

Elsevier

Access to resources Recommend Favorite

The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice

By Cataldo D.M.   Van Nest G.  

Vaccine, Vol. 15, Iss. 16, 1997-11 ,pp. : 1710-1715

Elsevier

Access to resources Recommend Favorite

MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice

By Higgins D.A.   Carlson J.R.   Van Nest G.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 478-484

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

By Minutello M.   Senatore F.   Cecchinelli G.   Bianchi M.   Andreani T.   Podda A.   Crovari P.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

By De Donato S.   Granoff D.   Minutello M.   Lecchi G.   Faccini M.   Agnello M.   Senatore F.   Verweij P.   Fritzell B.   Podda A.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3094-3101

Elsevier

Access to resources Recommend Favorite